** Jefferies analysts maintain "buy" rating on Australia's ALS Ltd ALQ.AX at a price target of A$18.80 per share
** The testing services provider will report its FY25 results on May 27
** According to Jefferies, ALQ's biggest delta, minerals, has had a negative sample volume growth, which has been a drag for the company in most of FY24 and FY25
** At the April 28 trading update, we got confirmation that this has flipped to being a positive driver — Jefferies
** Brokerage says there should be few surprises in the FY results; sees promising signs for medium-term growth
** Stock has risen 17.6% this year, as of last close
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.